| Literature DB >> 25550731 |
Zhi Kai Guo1, Rong Wang2, Wei Huang3, Xiao Nian Li4, Rong Jiang3, Ren Xiang Tan3, Hui Ming Ge3.
Abstract
An unusual C18 norditerpenoid, aspergiloid I (1), was isolated from the culture broth of Aspergillus sp. YXf3, an endophytic fungus derived from Ginkgo biloba. Its structure was unambiguously established by analysis of HRMS-ESI and spectroscopic data, and the absolute configuration was determined by low-temperature (100 K) single crystal X-ray diffraction with Cu Kα radiation. This compound is structurally characterized by a new carbon skeleton with an unprecedented 6/5/6 tricyclic ring system bearing an α,β-unsaturated spirolactone moiety in ring B, and represents a new subclass of norditerpenoid, the skeleton of which is named aspergilane. The hypothetical biosynthetic pathway for 1 was also proposed. The cytotoxic, antimicrobial, anti-oxidant and enzyme inhibitory activities of 1 were evaluated.Entities:
Keywords: Aspergillus; Ginkgo biloba; Trichocomaceae; endophytic fungus; natural product; norditerpenoid
Year: 2014 PMID: 25550731 PMCID: PMC4273245 DOI: 10.3762/bjoc.10.282
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Figure 1Structure of aspergiloid I (1) and its novel skeleton.
1H and 13C NMR spectroscopic data for aspergiloid I (1).
| Position | δCa | δHa (mult, | δCb | δHb (mult, |
| 1 | 28.5, CH2 | 1.96, td (13.5, 4.5, Hα); | 28.9 | 2.00, td (13.5, 4.0, Hα); |
| 2 | 18.1, CH2 | 1.63, m (Hα); | 18.2 | 1.87, qt (13.5, 4.0, Hα); |
| 3 | 31.8, CH2 | 1.51, m (overlap, Hα); | 32.0 | 1.53, td (13.5, 4.0, Hα); |
| 4 | 35.1, C | 35.3 | ||
| 5 | 76.9, CH | 2.81, d (7.0) | 79.0 | 3.09, br s |
| 5-OH | 5.21, d (7.0) | |||
| 6 | 88.6, C | 88.8 | ||
| 7 | 170.9, C | 171.5 | ||
| 8 | 23.7, CH2 | 2.56, ddd (20.0, 13.0, 4.5, Hα); | 23.7 | 2.78, dtd (20.0, 6.7, 1.5, Hα); 2.34, dtd (20.0, 6.0, 1.5, Hβ) |
| 9 | 28.4, CH2 | 1.61, td (13.0, 6.0, Hα); | 30.5 | 1.71, tdd (13.5, 7.5, 6.0, Hα); 1.64, dt (13.5, 6.0, Hβ) |
| 10 | 40.0, C | 39.9 | ||
| 11 | 64.7, CH | 3.76, d (6.5) | 67.4 | 4.31, s |
| 11-OH | 5.04, d (6.5) | |||
| 12 | 126.6, C | 126.9 | ||
| 13 | 171.6, C | 172.1 | ||
| 14 | 142.9, CH | 5.72, dd (17.5, 11.0) | 143.7 | 5.80, dd (17.2, 11.0) |
| 15 | 113.2, CH2 | 4.99, dd (17.5, 1.5, Hα); | 113.1 | 5.06, d (17.2, Hα); |
| 16 | 23.4, CH3 | 1.02, s | 20.1 | 1.08, s |
| 17 | 24.5, CH3 | 1.03, s | 24.6 | 1.17, s |
| 18 | 29.2, CH3 | 0.86, s | 28.6 | 0.97, s |
aAcquired in DMSO-d6 (125 MHz and 500 MHz). bAcquired in CDCl3 (125 MHz and 500 MHz).
Figure 2Selected 1H,1H-COSY and HMBC correlations and key NOEs observed for 1.
Figure 3X-ray single-crystal structure of 1.
Scheme 1Proposed biosynthetic pathway of 1.